(Q43810543)

27 November 2017

title

Treatment of acute disseminated encephalomyelitis (English)

1 reference

27 November 2017

Daniela Pohl

1

1 reference

27 November 2017

Silvia Tenembaum

series ordinal

2

1 reference

27 November 2017

publication date

1 June 2012

1 reference

Current treatment options in neurology

27 November 2017

published in

1 reference

27 November 2017

volume

14

1 reference

27 November 2017

issue

3

1 reference

27 November 2017

page(s)

264-275

1 reference

https://scigraph.springernature.com/pub.10.1007/s11940-012-0170-0

27 November 2017

exact match

0 references

cites work

Consensus definitions proposed for pediatric multiple sclerosis and related disorders

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Immune-mediated CNS diseases: a review on nosological classification and clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Epidemiology, immunopathogenesis and management of pediatric central nervous system inflammatory demyelinating conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Acute disseminated encephalomyelitis and its place amongst other acute inflammatory demyelinating CNS disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Postinfectious inflammatory disorders: subgroups based on prospective follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Acute disseminated encephalomyelitis: a follow-up study in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Paediatric multiple sclerosis and acute disseminated encephalomyelitis in Germany: results of a nationwide survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Clinical study of childhood acute disseminated encephalomyelitis, multiple sclerosis, and acute transverse myelitis in Fukuoka Prefecture, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Incidence of acquired demyelination of the CNS in Canadian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Acute disseminated encephalomyelitis in children: outcome and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Acute disseminated encephalomyelitis in North Indian children: clinical profile and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Long-term prognosis of pediatric patients with relapsing acute disseminated encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

An uncommon illness with a rare presentation: neurosurgical management of ADEM with tumefactive demyelination in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Acute disseminated encephalomyelitis: an acute hit against the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Long-term follow-up of neuromyelitis optica with a pediatric onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Anti-N-methyl-D-aspartate receptor encephalitis with acute disseminated encephalomyelitis-like MRI features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Acute disseminated encephalomyelitis-like manifestations in a patient with neuro-Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Acute disseminated encephalomyelitis in children: clinical features and HLA-DR linkage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Severe acute disseminated encephalomyelitis: a paediatric intensive care population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Acute disseminated encephalomyelitisin the intensive care unit:clinical features and outcome of 20 adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Acute disseminated encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

A comparison of MRI criteria for diagnosing pediatric ADEM and MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Clinical profile of acute disseminated encephalomyelitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Acute disseminated encephalomyelitis: a 10-year cohort study in Thai children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Immunomodulatory therapies in neurologic critical care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Update on investigation and management of postinfectious encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Life-saving hemicraniectomy for fulminant acute disseminated encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Decompressive craniectomy for acute disseminated encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Central brain herniation secondary to fulminant acute disseminated encephalomyelitis: implications for neurosurgical management. Case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Hemicraniectomy as a successful treatment of mass effect in acute disseminated encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Fulminant form of acute disseminated encephalomyelitis: successful treatment with hypothermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Pediatric acute hemorrhagic leukoencephalitis: report of a surviving patient and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Acute disseminated encephalomyelitis: a review of 18 cases in childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Acute disseminated encephalomyelitis in children: discordant neurologic and neuroimaging abnormalities and response to plasmapheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Acute disseminated encephalomyelitis: a long-term prospective study and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Descriptive study of acute disseminated encephalomyelitis and evaluation of functional outcome predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Steroid-responsive encephalomyelitis in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Acute disseminated encephalomyelitis: clinical and MRI study from South India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

The spectrum of postinfectious encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Acute disseminated encephalomyelitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Outcome of severe encephalomyelitis in children: effect of high-dose methylprednisolone and immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Multiple sclerosis vs acute disseminated encephalomyelitis in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Neuropsychological outcome after acute disseminated encephalomyelitis: impact of age at illness onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Relapsing Acute Disseminated Encephalomyelitis in Children: Further Evaluation of the Diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Acute disseminated encephalomyelitis (ADEM) after pertussis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Evaluation of the cases with acute disseminated encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Severe steroid-resistant post-infectious encephalomyelitis: general features and effects of IVIg

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Effectiveness of intravenous immunoglobulin treatment in adult patients with steroid-resistant monophasic or recurrent acute disseminated encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Improvement of atypical acute disseminated encephalomyelitis with steroids and intravenous immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Dramatic improvement of severe acute disseminated encephalomyelitis after treatment with intravenous immunoglobulin in a three-year-old boy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Use of therapeutic plasma exchange in the management of acute hemorrhagic leukoencephalitis: a case report and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: review of 50 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Post-traumatic cerebral infarction : outcome after decompressive hemicraniectomy for the treatment of traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Cerebellar mutism in pediatric acute disseminated encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Initial DWI and ADC imaging may predict outcome in acute disseminated encephalomyelitis: report of two cases of brain stem encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Cyclophosphamide therapy in pediatric multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0170-0

Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin

21 January 2018

1 reference

12 December 2020

Acute disseminated encephalomyelitis treated with plasmapheresis.

1 reference

12 December 2020

Immunoglobulins in acute, parainfectious, disseminated encephalo-myelitis

1 reference

12 December 2020

Pediatric gliomatosis cerebri mimicking acute disseminated encephalomyelitis

1 reference

12 December 2020

Combination regimen of methylprednisolone, IV immunoglobulin, and plasmapheresis early in the treatment of acute disseminated encephalomyelitis

1 reference

12 December 2020

Plasma exchange for severe attacks of CNS demyelination: predictors of response

1 reference

12 December 2020

Isolated bilateral optic neuritis in acute disseminated encephalomyelitis

1 reference

12 December 2020

Plasmapheresis in childhood acute disseminated encephalomyelitis.

1 reference

12 December 2020

Idiopathic transverse myelitis: corticosteroids, plasma exchange, or cyclophosphamide

1 reference

12 December 2020

Role of MRI in the differentiation of ADEM from MS in children

1 reference

12 December 2020

A case report of plasmapheresis in the treatment of acute disseminated encephalomyelitis

1 reference

12 December 2020

Rapid clinical and CSF response to intravenous gamma globulin in acute disseminated encephalomyelitis

1 reference

12 December 2020

Acute fulminant demyelinating disease: a descriptive study of 60 patients

1 reference

12 December 2020

Intravenous immunoglobulin in the treatment of acute disseminated encephalomyelitis.

1 reference

12 December 2020

Severe postvaccinia encephalitis with acute disseminated encephalomyelitis: recovery with early intravenous immunoglobulin, high-dose steroids, and vaccinia immunoglobulin

1 reference

12 December 2020

Acute disseminated encephalomyelitis in children: focus on relapsing patients

1 reference

12 December 2020

Acute disseminated encephalomyelitis in children. A descriptive study in Tehran, Iran.

1 reference

12 December 2020

Antibody responses to EBV and native MOG in pediatric inflammatory demyelinating CNS diseases

1 reference

12 December 2020

Treatment leading to dramatic recovery in acute hemorrhagic leukoencephalitis

1 reference

12 December 2020

Acute disseminated encephalomyelitis in children: one medical center experience.

1 reference

12 December 2020

Disease course and outcome of acute disseminated encephalomyelitis is more severe in adults than in children

1 reference

12 December 2020

10.1007/S11940-012-0170-0

Identifiers

DOI

1 reference

Dimensions Publication ID

27 November 2017

1046098601

0 references

Fatcat ID

release_zb22eupmpjchlgh2vj6l4vitsu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zb22eupmpjchlgh2vj6l4vitsu

24 November 2022

mapped directly with Wikidata item

1 reference